Pfizer's monopoly is very strong on the Covid-19 vaccines . They are spending millions hiding their side effects and creating hurdles for their competitors at the regulatory agencies SUCCESSFULLY . It maybe that Novavax has one the best products out there but that simply does not matter at this point , we know how powerful big pharma can be and Novavax's lateness...
✅MODERNA is making a rebound And will soon retest the resistance From where a pullback is likely With the target being the recent low SHORT🔥 ✅Like and subscribe to never miss a new idea!✅
$MRNA latest ... held point 4 (RSI 43s support) of the Jiego's Full Cycle RSI Framework .. Looking at Point 5.
The current price continues to dump PT $100 in the near term around 3 weeks.
You can buy MRNA target 447.6 stop loss 272.3 Money management your responsibility. I recommend entering a maximum of 10% of the portfolio. Good luck
Idea for MRNA: - Good level for reversal. Aug 13 is the capitulation date. - Stop is at 41 degrees. - Gamma squeeze bubble ends with big deflation. TP1: Gap fill 260~ PT 0.5 retrace of move: GLHF - DPT
Bullish Spring load. Decreasing volume at around 375-400 shows more gas to boost the rocket up.
Pivot on a huge impulse fractal confirmed. We are drawing more and more zigzags from now on. Our goals are shown. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more...
Moderna broke weekly support making this very vulnerable towards 237-250$/share. Will fall pretty hard in coming days - weeks iMO. Overvalued af in the high 400's nearly cut in half but not quite yet .. currently in puts.
Targeting 41$ .. Falling along with MRNA as vaccines should have less effect on peoples lives going forward. MRNA chart will be posted next and that one should move down further than a company like Pfizer. Pfizer has a future, Moderna really does not.
Merck data shows Molnupiravir will decrease mortality and hospitalization which is a good news, but do not forget it does not mean you do not need COVID-19 Vaccine..! This is only for those who becomes positive for COVID test, while Vaccine is for everyone! While many people debate about their choice of being vaccinated or not, I would like to show other...
10.3.21 MRNA Bobby's Homework Assignment : MRNA is likely to find buyers in this general area. We missed the buying tail... but this is not a big deal. This was a difficult video for reasons that I explain in the video. It is very important to start using the drawing tools to get familiarity and learn the process of using those tools to read the market. Use the...
Hello my beauties. I think MRNA has entered a distribution range, as the ST (second test) seemed to be pretty weak, and the price is now showing weakness below the trading range. We are going to wait for further developments in price action and eventually take a trade on the final LPSY. For those of you who like trading ranges, this might be a juicy opportunity....
Price volume decreased more than 70% Reviewing the previous corrections of 42%, 38%, and 24% in 3 days, make the price target of 240-270 possible for MRNA in October 2021.! Pay attention to the similarity of the Moderna chart with the Tesla chart in February 2021!
9.29.21 MRNA Bobby's assignment Part 2 ..................................